Last edition
News about Market
India’s pharma and healthcare sector recorded 65 deals worth USD 13.9 billion in Q2 2026, with record M&A values driven by strategic acquisitions and continued investor focus on specialty pharma, AI-enabled healthcare and innovation-led businesses.
Market | 24/07/2026 | By News Bureau | 218
Trump's Proposed Tariffs on Generic Drug Imports Raise Concerns for India's Pharmaceutical Industry
The US plans to impose a 100 percent tariff on imported generic medicines from August 2028, increasing to 200 percent a year later, prompting Indian drugmakers to reassess export strategies and manufacturing plans.
Market | 23/07/2026 | By News Bureau
Samsung Biologics to Acquire PolyPeptide in All-Cash Deal
Samsung Biologics has launched a CHF 1.46 billion all-cash offer to acquire PolyPeptide, expanding its global CDMO network and multi-modality strategy.
Market | 23/07/2026 | By News Bureau | 134
Ipsen Completes Acquisition of Memo Therapeutics AG
Ipsen has completed its acquisition of Memo Therapeutics AG, adding a first-in-class asset to strengthen its rare disease pipeline.
Market | 23/07/2026 | By News Bureau
Lupin Spins Out 2 Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
Lupin has spun off two oncology programs into Kaveri Therapeutics, retaining a significant equity stake while providing seed funding and exclusive program rights.
Market | 22/07/2026 | By News Bureau | 110
The collaboration between Insilico Medicine and Bora Pharmaceuticals is valued at over USD 2.5 billion if fully implemented and aims to accelerate the discovery, development and commercialisation of next-generation therapies while expanding AI adoption across the pharmaceutical value chain.
Market | 16/07/2026 | By News Bureau | 154
India-UK FTA to Boost Pharma Exports Beyond USD 981 Million in FY2026-27: Pharmexcil
India-UK FTA is expected to boost India's pharmaceutical exports to the UK beyond USD 981 million in FY2026-27, building on strong export growth, according to Pharmexcil.
Market | 16/07/2026 | By News Bureau | 123
UK and EU Drugs Agency Sign Pact to Strengthen Response to Emerging Drug Threats
The UK government and the European Union Drugs Agency (EUDA) have signed a new cooperation agreement to enhance intelligence sharing on emerging drug threats, strengthen public health protection and improve coordinated action against illicit drug trafficking across Europe.
Market | 15/07/2026 | By News Bureau | 134
AstraZeneca Enters into Global License Agreement with with Dizal Pharmaceutical for Zegfrovy
AstraZeneca has entered a global licensing agreement with Dizal Pharmaceutical for Zegfrovy, expanding its EGFR-targeted lung cancer portfolio.
Market | 15/07/2026 | By News Bureau | 124
Sun Pharma Receives Approval to Manufacture and Market Generic Semaglutide in South Africa
Sun Pharma has received approval to manufacture and market generic semaglutide in South Africa, available as a once-weekly pre-filled multi-dose injectable pen in 2 strengths.
Market | 15/07/2026 | By News Bureau | 101
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy